{"transactions":[{"id":731904,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:15:50.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":90316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":90316,"derivative":{"underlying":"Common Stock","underlying_shares":90316},"source":{"system":"sec-edgar","filing":"0001104659-26-075856","document":"tm2618145-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075856/tm2618145-2_4seq1.xml","form_type":"4"}},{"id":884309,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-24T21:02:39.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":5.75,"value":2300000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on February 23, 2027, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested."}],"balance_after":400000,"derivative":{"exercise_price":5.75,"expiration_date":"2036-02-22","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001363984-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363984/000136398426000004/primarydocument.xml","form_type":"4"}},{"id":1107835,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2025-06-17T20:08:31.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":67546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":67546,"derivative":{"underlying":"Common Stock","underlying_shares":67546},"source":{"system":"sec-edgar","filing":"0001104659-25-060253","document":"tm2518181-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925060253/tm2518181-4_4seq1.xml","form_type":"4"}},{"id":1365023,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-14T22:00:09.000Z","date":"2024-11-12","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":7.45,"exercise_date":"2016-02-16","expiration_date":"2025-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-119195","document":"tm2428483-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924119195/tm2428483-1_4seq1.xml","form_type":"4"}},{"id":1365022,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T22:00:09.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":10.06,"value":503000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-24-119195","document":"tm2428483-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924119195/tm2428483-1_4seq1.xml","form_type":"4"}},{"id":1365021,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T22:00:09.000Z","date":"2024-11-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":7.45,"value":372500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."}],"balance_after":57500,"source":{"system":"sec-edgar","filing":"0001104659-24-119195","document":"tm2428483-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924119195/tm2428483-1_4seq1.xml","form_type":"4"}},{"id":1480465,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2024-06-13T22:00:55.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":49303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":49303,"derivative":{"underlying":"Common Stock","underlying_shares":49303},"source":{"system":"sec-edgar","filing":"0001104659-24-071370","document":"tm2417165-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924071370/tm2417165-2_4seq1.xml","form_type":"4"}},{"id":1595400,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2024-03-05T22:55:31.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-031112","document":"tm248017d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924031112/tm248017d8_4seq1.xml","form_type":"4"}},{"id":1648856,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-12T22:15:08.000Z","date":"2023-02-08","kind":"sale","planned":true,"acquired":false,"shares":5488,"price":0.53,"value":2908.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on September 14, 2023 accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":8012,"source":{"system":"sec-edgar","filing":"0001415889-24-003404","document":"form4-02122024_100201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924003404/form4-02122024_100201.xml","form_type":"4"}},{"id":1658386,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-05T21:32:05.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that vested under a performance-based restricted stock unit award (the \"Award\") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001415889-24-002528","document":"form4-02052024_090254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924002528/form4-02052024_090254.xml","form_type":"4"}},{"id":1862115,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2023-06-08T22:21:39.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":51955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":51955,"derivative":{"underlying":"Common Stock","underlying_shares":51955},"source":{"system":"sec-edgar","filing":"0001104659-23-069507","document":"tm2318216-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923069507/tm2318216-4_4seq1.xml","form_type":"4"}},{"id":1972290,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:38:07.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":81000,"derivative":{"exercise_price":10.06,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001209191-23-015571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123015571/doc4.xml","form_type":"4"}},{"id":2159180,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-14T20:42:23.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares will vest and become exercisable on September 12, 2023 and the remainder will vest over the following 36 equal monthly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date."}],"balance_after":225000,"derivative":{"exercise_price":10.75,"expiration_date":"2032-09-12","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-22-049931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122049931/doc4.xml","form_type":"4"}},{"id":2232529,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2022-06-14T21:02:42.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":51204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":51204,"derivative":{"underlying":"Common Stock","underlying_shares":51204},"source":{"system":"sec-edgar","filing":"0001104659-22-071054","document":"tm2218366-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071054/tm2218366-5_4seq1.xml","form_type":"4"}},{"id":2247345,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T00:02:55.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":7500,"price":6.745,"value":50587.5,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-22-067762","document":"tm2217576d4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922067762/tm2217576d4_4seq1.xml","form_type":"4"}},{"id":2647484,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T20:18:49.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022."}],"balance_after":35000,"derivative":{"exercise_price":26.33,"expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-21-088251","document":"tm2121236-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465921088251/tm2121236-3_4seq1.xml","form_type":"4"}},{"id":3114621,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T00:00:37.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 8, 2021."}],"balance_after":35000,"derivative":{"exercise_price":32.17,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-20-072138","document":"tm2022303d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920072138/tm2022303d2_4.xml","form_type":"4"}},{"id":3494039,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T21:16:16.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service, unless the Reporting Person is terminated for cause, in which case the options shall terminate immediately."}],"balance_after":35000,"derivative":{"exercise_price":19.93,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-19-030595","document":"tv523380_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000114420419030595/tv523380_4.xml","form_type":"4"}},{"id":3864417,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-19T21:07:21.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service, unless the Reporting Person is terminated for cause, in which case the options shall terminate immediately."}],"balance_after":35000,"derivative":{"exercise_price":14.45,"expiration_date":"2028-07-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001250853-18-000100","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085318000100/primary_doc.xml","form_type":"4"}},{"id":4170362,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-11-08T02:07:01.000Z","date":"2017-11-03","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested monthly over two years from January 1, 2015."}],"balance_after":75000,"derivative":{"exercise_price":2.14,"expiration_date":"2025-01-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-17-013850","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017013850/edgar.xml","form_type":"4"}},{"id":4170361,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2017-11-08T02:07:01.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":100000,"price":3.9,"value":390000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-013850","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017013850/edgar.xml","form_type":"4"}},{"id":4170360,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2017-11-08T02:07:01.000Z","date":"2017-11-03","kind":"exercise","acquired":true,"shares":100000,"price":2.14,"value":214000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001179110-17-013850","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017013850/edgar.xml","form_type":"4"}},{"id":4292804,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-05T21:34:24.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated."}],"balance_after":35000,"derivative":{"exercise_price":5.45,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001250853-17-000051","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085317000051/primary_doc.xml","form_type":"4"}},{"id":4347866,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T21:50:15.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2016 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option."}],"balance_after":150000,"derivative":{"exercise_price":2.74,"expiration_date":"2026-01-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-006153","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017006153/edgar.xml","form_type":"4"}},{"id":4347865,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T21:50:15.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 27, 2014 the reporting person was granted an option to purchase 125,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 62,500 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 62,500 shares of common stock, resulting in full vesting of the option."}],"balance_after":62500,"derivative":{"exercise_price":3.59,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-17-006153","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017006153/edgar.xml","form_type":"4"}},{"id":4466628,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T00:24:55.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over four (4) years from January 1, 2017."}],"balance_after":150000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-001817","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017001817/edgar.xml","form_type":"4"}}]}